Form 4 for KURA Kura Oncology, Inc.
Accepted 2024-01-26 00:00:00 ET · period of report 2024-01-24 · accession 0000950170-24-008020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-01-26 | 2024-01-24 | KURA | WILSON TROY EDWARD | Pres, CEO, Dir | M - OptEx | $6.05 | +91.1K | 7,504 | New | +$550.6K |
| M | 2024-01-26 | 2024-01-24 | KURA | WILSON TROY EDWARD | Pres, CEO, Dir | S - Sale+OE | $20.23 | -91.1K | 559 | -99% | -$1.84M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-24 | M | A | 84,107 | $6.15 | 84,666 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-24 | S | D | 6,945 | $20.23 | 559 | D | — | — | |
| 3 | Common | Common Stock | 2024-01-24 | M | A | 6,945 | $4.80 | 7,504 | D | — | — | |
| 4 | Common | Common Stock | 2024-01-24 | S | D | 84,107 | $20.23 | 559 | D | — | — |